TrialCell reports. Medicine2025

Hormone therapy enhances anti-PD1 efficacy in premenopausal estrogen receptor-positive and HER2-negative advanced breast cancer.

I-Chun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.